Fetomaternal outcome in patients with early preterm labour following administration of magnesium sulphate - a hospital based prospective study
Objective: To assess the effectiveness of magnesium sulfate as a neuroprotective agent in early preterm labour (28 to 32 weeks). To assess any maternal or fetal adverse effects after giving magnesium sulfate. Methods: Hospital based prospective observational study. Initially 72 pregnant women with p...
Main Authors: | Robin Medhi, Indira Das, Rumen Ch Boro, Wahida Naznin |
---|---|
Format: | Article |
Language: | English |
Published: |
Barpeta Obstetrics and Gynaecological Society
2023-08-01
|
Series: | New Indian Journal of OBGYN |
Subjects: | |
Online Access: | http://journal.barpetaogs.co.in/pdf/01039.pdf |
Similar Items
-
Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU
by: Mariam Ayed, et al.
Published: (2022-06-01) -
School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
by: Akira Kobayashi, et al.
Published: (2023-07-01) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017-09-01) -
Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor
by: Ali Akbar Taherian, et al.
Published: (2007-07-01) -
Nifedipin versus magnesium sulfate for suppression of preterm labor: A randomized Clinical trial
by: Sedigheh Esmaeilzadeh, et al.
Published: (2017-04-01)